As the clinical experience with HDF accumulates globally, it is worth examining the evidence for this kidney replacement therapy as used in routine clinical care. Such real-world evidence is increasingly recognized as valuable by clinicians and may inform regulatory decisions. In this presentation, we will focus on emerging global real-world data derived from routine clinical practices and examine how these data may complement those derived from clinical trials.
Event Date: 5/8/2024